We conducted a genome-wide association pooling study for cutaneous melanoma and performed validation in samples totaling 2,019 cases and 2,105 controls. Using pooling, we identified a new melanoma risk locus on chromosome 20 (rs910873 and rs1885120), with replication in two further samples (combined P o 1 Â 10 À15 ). The per allele odds ratio was 1.75 (1.53, 2.01), with evidence for stronger association in early-onset cases.
Cutaneous melanoma is an important health problem in fairskinned populations worldwide, and its incidence is rising in most 1 . An understanding of the genetic factors influencing melanoma risk and the identification of susceptible individuals may aid in increasing sun protection and early detection of the disease in populations at risk. Four high-penetrance melanoma risk loci have been identified (CDKN2A, ARF, CDK4 and a locus on 1p22) 2 , and MC1R has been validated as a gene harboring low-penetrance risk alleles 3, 4 .
To identify additional low-penetrance risk alleles, we carried out a genome-wide association study (GWAS) involving the pooling of 864 cases drawn from a larger population-based sample of cases (individuals with melanoma) from Queensland, unselected for age at onset (Queensland study of Melanoma: Environment and Genetic Associations (Q-MEGA) 5 ), and 864 controls (Q1). Each pool was hybridized to six Illumina HumanHap550 arrays, and SNPs were ranked after accounting for pooling error 6, 7 . The proportion of SNPs with P values from pooling of o0.01 was consistent with what would be expected by chance if there were no true associations. Conversely, at smaller P-value thresholds, there were more SNPs than expected by chance. For example, at the 0.0001 threshold, we would expect to see B55 SNPs under the null hypothesis of no association, but we in fact observed 90 SNPs, indicating that there were a number of true associations (Supplementary Note online).
Here we focus on only the most significant finding from pooling. The first-ranked (rs17305657, P ¼ 2.56 Â 10 À7 ) and fourth-ranked (rs4911442, P ¼ 2.39 Â 10 À6 ) SNPs are 1.5 Mb apart on chromosome 20. Multiple other SNPs in this region showed evidence for association ( Supplementary Fig. 1 online) . When the pooling results were validated by individual genotyping, concordance was excellent (rs17305657, P ¼ 3.63 Â 10 À6 ; rs4911442, P ¼ 1.03 Â 10 À8 ). To fine map this region, we selected 31 additional SNPs that span B2.78 Mb in chromosome bands 20q11.21-q11.22 (Supplementary Methods online). Selection was based on candidate genes, pooling results, ethnic allele frequency differences and linkage disequilibrium (LD) patterns (that is, SNPs whose presence correlated with that of both rs17305657 and rs4911442; Supplementary Methods). We then genotyped the set of 33 SNPs in three sample sets: 789 cases and 854 controls from the pooled Q-MEGA subjects (Q1); a second set of 725 cases and 797 controls sampled independently from Q-MEGA (Q2); and 505 cases and 454 controls (A1) from an independent populationbased study of melanoma diagnosed before age 40 years, ascertained in Brisbane, Melbourne and Sydney (Australian Melanoma Family Study (AMFS); A. Cust, unpublished data). The combined sample comprised 2,019 cases and 2,105 controls, all of European descent. All cases had incident primary melanomas (stage 1). Figure 1 shows the association results for Q1, Q2 and A1 (see also Supplementary Tables 1-5 online). Several SNPs showed stronger evidence for association than the two SNPs identified using the HumanHap550 array. In each of the samples, two SNPs were highly associated with melanoma, rs910873 and rs1885120 ( Fig. 1) , with combined P o 1 Â 10 À15 (Fig. 2) .
To determine whether a single SNP could account for the association signal in this region, we analyzed multiple SNPs jointly by logistic regression. The effects of rs910873 and rs1885120 could not be separated (fitting one in the model rendered the other redundant, r 2 4 0.9 both in cases and controls). Given the high r 2 value between rs910873 and rs1885120, we cannot unambiguously identify the interval in which the causal variant(s) lie. When either SNP was fitted in the logistic regression, all other SNPs typed in the vicinity were redundant (Supplementary Table 6 online). There was some evidence for residual association around rs17305657, indicating there may be two independent signals in this region of chromosome 20 (either in the same or in different genes). Alternatively, both SNPs may be in incomplete LD with a single causal variant.
We tested whether the observed association at rs910873 could be explained by any of the obvious candidate genes in the region. SNPs rs2071054 and rs3213182 lie in or near E2F1, which encodes a transcription factor regulated by the retinoblastoma protein, but neither showed evidence for association once the effect of rs910873 (or rs1885120) was accounted for (Supplementary Table 6) . Similarly, rs819163, rs6059743 and rs819162, within or adjacent to ASIP, showed little evidence for residual association (smallest P ¼ 0.062; Supplementary Table 6 ). ASIP encodes the human ortholog of the murine agouti gene product, a paracrine signaling molecule and antagonist of a-melanocytestimulating hormone (the ligand of the MC1R gene product), which regulates synthesis of melanin. In humans, a SNP in the 3¢ untranslated region of ASIP has been associated with variation in pigmentation 8-10 but has not been independently associated with nevi or melanoma risk 4, 8, 10 . Although we have not genotyped all variants in ASIP and E2F1, our findings provide evidence that a risk variant for melanoma lies in a more telomeric region that includes several other candidate loci.
It is noteworthy that rs910873 (and, through LD, rs1885120) is polymorphic only in Caucasian (CEU) and not in Asian (JPT or CHB) or African (YRI) HapMap samples. Furthermore, in our dataset, the frequency of the risk alleles for rs910873 and rs1885120 was significantly higher in melanoma cases (frequency 0.15) than controls (frequency 0.09). Because population stratification may cause falsepositive associations in non-homogeneous samples, we assessed the self-reported ancestry for all four grandparents in a subset of 1,779 controls and 597 cases from Q1 and Q2 for which data were available. The vast majority of controls (n ¼ 1,438) and cases (n ¼ 585) reported 100% Northern European ancestry (others had one or more grandparents with Southern European ancestry). In the Northern European subset, allele frequencies were very similar (within 0.01) to those found in the whole sample, implying that population stratification (even within Europe) could not explain the results.
To further describe the phenotypic associations of the peak SNPs, we examined age at onset using rs910873. In Q1 and Q2, we used two criteria, r40 years and r30 years. Because all A1 cases had age at onset r40 years, we stratified this sample only at r30. Results for Q2 indicated that the age-at-onset threshold of r40 was important (r40 subset per allele odds ratio (OR) ¼ 40, 2.51) ). Age at onset was not significant in Q1 (data not shown), the discovery sample that was ascertained without respect to age at onset. Overall, rs910873 (and, through LD, rs1885120) seems to be related to early onset.
To provide an unbiased estimate of the OR and populationattributable fraction (PAF), we used the two replication samples Q2 and A1. The ORs were 1.72 (1.48, 2.14) and 1.81 (1.52, 2.17) for all cases and r40 age at onset groups, respectively. The PAFs in these samples from the Australian population were 0.11 (0.08, 0.16) and 0.12 (0.08, 0.17) for all cases and r40 age at onset groups, respectively.
The most strongly associated region between rs910873 and rs1885120 is B400 kb in length. rs1885120 maps within an intron of MYH7B (myosin, heavy polypeptide 7B, cardiac muscle, beta), which is not expressed in a large panel of melanoma cell lines analyzed 11 . rs910873 maps within an intron of PIGU (also known as CDC91L1), which encodes phosphatidylinositol glycan anchor biosynthesis class U and is expressed in all melanoma cell lines assessed, as are TP53INP2 (encoding tumor protein p53-inducible nuclear protein-2), NCOA6 (encoding nuclear receptor coactivator-6), GGTL3 (encoding gamma-glutamyltransferase-like-3), ACSS2 (encoding acylCoA synthetase short-chain family member 2) and GSS (encoding glutathione synthetase), the other genes that map between these two SNPs.
In summary, we have identified a new melanoma risk locus and replicated this association in two independent samples, with a combined P o 1 Â 10 À15 . The effect size for melanoma associated with this genomic region is of similar magnitude to that associated with MC1R (OR B2, PAF B0.1 for heterozygotes) 3, 4 , the only lowpenetrance melanoma susceptibility gene identified to date whose association has been robustly replicated. Identification of the causal variants associated with melanoma predisposition at 20q11.22 will help refine the estimates of risk for this increasingly common cancer.
Note: Supplementary information is available on the Nature Genetics website.
